Research Article Open Access Double-Blind Peer Review

PHARMACOLOGICAL STRATEGIES FOR CEREBROVASCULAR ACCIDENT MANAGEMENT IN THE INTENSIVE CARE UNIT: INSIGHTS FROM COCODY UNIVERSITY HOSPITAL

Marie-Louise T. and Jean-Pierre A. Gboa and Yao
Published 28 June 2024
Vol. 1, No. 1 (2024)
pp. 12-19
CC BY 4.0
  1. 1
    Marie-Louise T. and Jean-Pierre A. Gboa and Yao
    Pharmacology Laboratory, UFR Pharmaceutical Sciences, FHB University, Abidjan, Ivory Coast, 2Pharmacy Unit, Cocody University Hospital, Ivory Coast.
    CI

A cerebrovascular accident (CVA), commonly known as a stroke, presents a critical medical emergency characterized by the sudden disruption of blood flow to the brain, leading to neurological damage. This condition, if not promptly addressed within a narrow therapeutic window of 24 hours, can have grave consequences, ranging from death to irreversible impairment of brain function. Hepburn et al. (2018) highlight the severity of CVAs and underscore the urgent need for timely intervention to mitigate their debilitating effects. This abstract underscores the urgency and gravity of cerebrovascular accidents, emphasizing the critical importance of swift and effective intervention to prevent adverse outcomes. The 24-hour window following a CVA represents a crucial period during which medical interventions can significantly influence patient prognosis and outcomes. By providing timely and appropriate treatment, healthcare professionals can minimize neurological damage and improve patient survival and quality of life.

JournalJournal of Medical Technology and Innovation
ISSN3065-0607
Volume / IssueVol. 1, No. 1 (2024)
Pages12-19
Published28 June 2024
Access Open Access
LicenseCC BY 4.0 — reuse with attribution
PublisherKeith Publications
Gboa and Yao, M. (2024). PHARMACOLOGICAL STRATEGIES FOR CEREBROVASCULAR ACCIDENT MANAGEMENT IN THE INTENSIVE CARE UNIT: INSIGHTS FROM COCODY UNIVERSITY HOSPITAL . Journal of Medical Technology and Innovation, Vol. 1 No. 1, pp. 12-19

 Submit Your Research to Journal of Medical Technology and Innovation

We invite original research articles, review papers, and case studies. Benefit from rigorous double-blind peer review, rapid decision within 4–8 weeks, DOI for every article, and worldwide open-access distribution.